Reference Data
| Compound | Larazotide |
|---|---|
| Strength | 500MCG per capsule |
| Count | 60 capsules |
| Format | GMP finished capsule research product |
| Research Focus | Tight-junction signaling, intestinal barrier pathway research, epithelial permeability models, gut-barrier response biology, inflammatory signaling, immune-gut interface research, and gastrointestinal pathway studies. |
Reference figures are provided for research identification. Always confirm against the batch-specific Certificate of Analysis.
Tight-Junction Research
Studied in models involving tight-junction signaling, epithelial barrier behavior, and paracellular permeability pathway research.
500MCG Capsule Format
Microgram-strength capsule format with clear labeling for controlled laboratory models requiring consistent product presentation.
GMP Capsule Quality
Finished capsule format produced with GMP-focused standards, capsule consistency review, and product documentation checks.
Why Larazotide Matters in Research
Larazotide is studied in laboratory models involving intestinal epithelial barrier systems, tight-junction signaling, paracellular permeability biology, gut-barrier response pathways, and inflammatory signaling environments.
Tight-junction pathway research is important in controlled laboratory models because epithelial barrier behavior influences how researchers study permeability, gut-barrier integrity, immune-gut signaling, and gastrointestinal cellular response systems.
The 500MCG capsule format gives researchers a clearly labeled microgram-strength presentation for studies involving barrier-response comparison, epithelial pathway behavior, and gastrointestinal signaling models under controlled experimental conditions.
- 500MCG Larazotide per capsule
- 60 GMP capsules per bottle
- Studied in tight-junction and intestinal barrier pathway research
- Relevant to epithelial permeability and gut-barrier response models
- Used in inflammatory signaling and immune-gut interface pathway studies
- Microgram-strength finished capsule format with internal QA review
Research Applications
- Intestinal barrier pathway research
- Tight-junction signaling models
- Epithelial permeability studies
- Gut-barrier response biology
- Inflammatory pathway research
- Immune-gut interface models
- Gastrointestinal cellular signaling studies
- Barrier integrity comparison research
Why Our Quality Process Is Different
Microgram-strength capsule research products require careful attention to ingredient handling, capsule consistency, raw material documentation, finished-product presentation, labeling accuracy, and storage expectations.
Disguised Alpha reviews Larazotide as a complete GMP capsule research product with attention to microgram-strength labeling clarity, product documentation, internal QA, capsule presentation, and direct fulfillment accountability.
- GMP capsule manufacturing standards
- Microgram-strength labeling clarity
- Finished capsule presentation review
- Product documentation and labeling checks
- Internal QA before product release
- Direct in-house fulfillment with no anonymous 3PL handling
Verify Our Claims
We believe researchers should be able to verify the standards we speak about. Learn more about the independent laboratories we work with below.
The Disguised Alpha Standard
Disguised Alpha is built around direct accountability. Every order is processed, inspected, packaged, and shipped by our in-house team instead of being passed off to a third-party logistics warehouse.
This gives us tighter control over fulfillment accuracy, packaging quality, storage standards, and customer experience. Our goal is not to be the cheapest research supplier — it is to provide professionally handled compounds with real quality oversight behind them.
Larazotide is sold strictly for laboratory and in-vitro research. It is not for human consumption, veterinary use, or any diagnostic or therapeutic application. Nothing on this page is medical, dosing, or therapeutic advice.